Frontiers in Oncology (Jan 2024)

Death-associated protein 3 in cancer—discrepant roles of DAP3 in tumours and molecular mechanisms

  • Hao Song,
  • Hao Song,
  • Huifang Liu,
  • Huifang Liu,
  • Xiufeng Wang,
  • Yuteng Yang,
  • Yuteng Yang,
  • Xiangkun Zhao,
  • Xiangkun Zhao,
  • Wen G. Jiang,
  • Laijian Sui,
  • Xicheng Song

DOI
https://doi.org/10.3389/fonc.2023.1323751
Journal volume & issue
Vol. 13

Abstract

Read online

Cancer, ranks as the secondary cause of death, is a group of diseases that are characterized by uncontrolled tumor growth and distant metastasis, leading to increased mortality year-on-year. To date, targeted therapy to intercept the aberrant proliferation and invasion is crucial for clinical anticancer treatment, however, mutant expression of target genes often leads to drug resistance. Therefore, it is essential to identify more molecules that can be targeted to facilitate combined therapy. Previous studies showed that death associated protein 3 (DAP3) exerts a pivotal role in regulating apoptosis signaling of tumors, meanwhile, aberrant DAP3 expression is associated with the tumorigenesis and disease progression of various cancers. This review provides an overview of the molecule structure of DAP3 and the discrepant roles played by DAP3 in various types of tumors. Considering the molecular mechanism of DAP3-regulated cancer development, new potential treatment strategies might be developed in the future.

Keywords